Clinical Trial Update: Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating immunogenicity, efficacy, and safety of human-cl rhFVIII in severe Hemophilia A; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• rhFVIII (rhFVIII)

Snippet

Sponsor: Octapharma | Conditions: Severe Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2019-12-17